Lista de obras - Tom Stargardt - Dominio Público Uruguay

A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data

artículo científico publicado en 2012

Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

artículo científico publicado en 2018

Authors’ response to “Health service expenditures and efficiencies in Greece” (I) ⬇️

artículo científico publicado el 23 de mayo de 2013

Availability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema and chronic myeloid leukaemia

scientific article published on 01 January 2011

Blood donation and donors: insights from a large German teaching hospital (2008-2017)

scientific article published on 22 October 2019

Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation

artículo científico publicado en 2016

Correction to: Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

scientific article published on 01 September 2018

Cost effectiveness of drug-eluting stents in acute myocardial infarction patients in Germany: results from administrative data using a propensity score-matching approach

artículo científico publicado en 2012

Cost of illness and economic burden of chronic lymphocytic leukemia

artículo científico publicado en 2013

Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.

artículo científico publicado en 2016

Cost-Utility of Internet-Based Cognitive Behavioral Therapy in Unipolar Depression: A Markov Model Simulation

scientific article published on 15 February 2020

Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer

artículo científico publicado en 2010

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data ⬇️

artículo científico publicado el 19 de febrero de 2013

Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching ⬇️

artículo científico publicado el 8 de octubre de 2011

Cost-utility analysis comparing heavy-weight and light-weight mesh in laparoscopic surgery for unilateral inguinal hernias

artículo científico publicado en 2014

Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach

scientific article published on 24 July 2018

Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis

artículo científico publicado en 2020

Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)-A large population-based cohort study

artículo científico publicado en 2016

Costs and quality of hospitals in different health care systems: a multi-level approach with propensity score matching

scientific article published on 18 January 2010

Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories

artículo científico publicado en 2008

Determining the "Health Benefit Basket" of the Statutory Health Insurance scheme in Germany: methodologies and criteria

artículo científico publicado en 2005

Dispensing behaviour of pharmacies in prescription drug markets

artículo científico publicado en 2016

Do discontinuities in marginal reimbursement affect inpatient psychiatric care in Germany?

artículo científico publicado en 2020

Early benefit assessment of pharmaceuticals in Germany: manufacturers' expectations versus the Federal Joint Committee's decisions

artículo científico publicado en 2014

Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature

artículo científico publicado en 2016

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches

scientific article published on 11 February 2010

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches

artículo científico publicado en 2010

Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care

artículo científico publicado en 2008

Effectiveness and cost of atypical versus typical antipsychotic treatment in a nationwide cohort of patients with schizophrenia in Germany.

artículo científico publicado en 2012

Effectiveness and costs of flupentixol compared to other first- and second-generation antipsychotics in the treatment of schizophrenia

artículo científico publicado en 2011

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes

artículo científico publicado en 2009

Focus on designing health care structures and services for rare diseases

article

Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia

artículo científico publicado en 2016

Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries

artículo científico publicado en 2008

Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort

artículo científico publicado en 2016

Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK

artículo científico publicado en 2020

Impact of cross-reference pricing on pharmaceutical prices: manufacturers' pricing strategies and price regulation

artículo científico publicado en 2006

Inpatient costs and predictors of costs in the psychosomatic treatment of anorexia nervosa

artículo científico publicado en 2011

Introduction of DRG-based reimbursement in inpatient psychosomatics--an examination of cost homogeneity and cost predictors in the treatment of patients with eating disorders.

artículo científico publicado en 2012

Measuring the relationship between costs and outcomes: the example of acute myocardial infarction in German hospitals

artículo científico publicado en 2013

Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries

artículo científico publicado en 2006

Modelling pharmaceutical price changes in Germany: a function of competition and regulation

article

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

artículo científico publicado en 2020

Performance of compliance and persistence measures in predicting clinical and economic outcomes using administrative data from German sickness funds.

artículo científico publicado en 2012

Pharmaceutical Pricing in Germany: How Is Value Determined within the Scope of AMNOG?

artículo científico

Preferred supplier contracts in post-patent prescription drug markets

artículo científico publicado en 2016

Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany

artículo científico publicado en 2007

Reforms in the Greek pharmaceutical market during the financial crisis ⬇️

artículo científico publicado el 7 de septiembre de 2012

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment ⬇️

artículo científico publicado el 28 de agosto de 2010

Service quality and perceived customer value in community pharmacies

artículo científico publicado en 2018

The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective

scientific article published on 01 August 2019

The Trade-off Between Costs and Quality of Care in the Treatment of Psychosomatic Patients with Somatoform Pain Disorder ⬇️

artículo científico publicado el 1 de agosto de 2013

The diffusion of generics after patent expiry in Germany

artículo científico publicado en 2015

The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study

artículo científico publicado en 2014

The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany

artículo científico publicado en 2020

The impact of physician-level drug budgets on prescribing behavior

artículo científico publicado en 2017

The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany

artículo científico publicado en 2009

The trade-off between costs and outcomes: the case of acute myocardial infarction

artículo científico publicado en 2010

Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation

artículo científico publicado en 2017

United but divided: Policy responses and people's perceptions in the EU during the COVID-19 outbreak

artículo científico publicado en 2020

User engagement and the role of mHealth in self-management of diabetes: Real-world evidence from the Cornerstones4Care® app

scientific article published on 24 September 2020

Lista de obras de Tom Stargardt

A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data

Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

Authors’ response to “Health service expenditures and efficiencies in Greece” (I) ⬇️

Availability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema and chronic myeloid leukaemia

Blood donation and donors: insights from a large German teaching hospital (2008-2017)

Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation

Correction to: Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

Cost effectiveness of drug-eluting stents in acute myocardial infarction patients in Germany: results from administrative data using a propensity score-matching approach

Cost of illness and economic burden of chronic lymphocytic leukemia

Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.

Cost-Utility of Internet-Based Cognitive Behavioral Therapy in Unipolar Depression: A Markov Model Simulation

Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data ⬇️

Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching ⬇️

Cost-utility analysis comparing heavy-weight and light-weight mesh in laparoscopic surgery for unilateral inguinal hernias

Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach

Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis

Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)-A large population-based cohort study

Costs and quality of hospitals in different health care systems: a multi-level approach with propensity score matching

Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories

Determining the "Health Benefit Basket" of the Statutory Health Insurance scheme in Germany: methodologies and criteria

Dispensing behaviour of pharmacies in prescription drug markets

Do discontinuities in marginal reimbursement affect inpatient psychiatric care in Germany?

Early benefit assessment of pharmaceuticals in Germany: manufacturers' expectations versus the Federal Joint Committee's decisions

Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches

Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care

Effectiveness and cost of atypical versus typical antipsychotic treatment in a nationwide cohort of patients with schizophrenia in Germany.

Effectiveness and costs of flupentixol compared to other first- and second-generation antipsychotics in the treatment of schizophrenia

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes

Focus on designing health care structures and services for rare diseases

Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia

Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries

Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort

Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK

Impact of cross-reference pricing on pharmaceutical prices: manufacturers' pricing strategies and price regulation

Inpatient costs and predictors of costs in the psychosomatic treatment of anorexia nervosa

Introduction of DRG-based reimbursement in inpatient psychosomatics--an examination of cost homogeneity and cost predictors in the treatment of patients with eating disorders.

Measuring the relationship between costs and outcomes: the example of acute myocardial infarction in German hospitals

Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries

Modelling pharmaceutical price changes in Germany: a function of competition and regulation

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

Performance of compliance and persistence measures in predicting clinical and economic outcomes using administrative data from German sickness funds.

Pharmaceutical Pricing in Germany: How Is Value Determined within the Scope of AMNOG?

Preferred supplier contracts in post-patent prescription drug markets

Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany

Reforms in the Greek pharmaceutical market during the financial crisis ⬇️

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment ⬇️

Service quality and perceived customer value in community pharmacies

The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective

The Trade-off Between Costs and Quality of Care in the Treatment of Psychosomatic Patients with Somatoform Pain Disorder ⬇️

The diffusion of generics after patent expiry in Germany

The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study

The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany

The impact of physician-level drug budgets on prescribing behavior

The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany

The trade-off between costs and outcomes: the case of acute myocardial infarction

Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation

United but divided: Policy responses and people's perceptions in the EU during the COVID-19 outbreak

User engagement and the role of mHealth in self-management of diabetes: Real-world evidence from the Cornerstones4Care® app